掌跖脓疱病患者中斑块状银屑病的特征与患病率
合并银屑病的PPP患者银屑病关节炎患病率和抗银屑病药物使用率更高,尤其是生物制剂。
要点
- 合并银屑病的PPP患者银屑病关节炎和生物制剂使用更常见。
核心结论
- 合并银屑病的PPP患者银屑病关节炎患病率和抗银屑病药物使用率更高。
研究设计与样本
- 基于美国、丹麦和德国行政医疗登记与保险数据库的观察性研究。
- PPP定义为1年内单次国际疾病分类第10版PPP编码。
- 美国、丹麦和德国分别识别1435、751和1832例PPP患者。
主要发现
- 合并银屑病的PPP患者银屑病关节炎总体患病率更高。
- 合并银屑病的PPP患者抗银屑病药物使用更普遍,尤其是生物制剂。
临床怎么用
- 在PPP患者中应评估斑块状银屑病共存,并关注银屑病关节炎。
- 合并银屑病的PPP患者可能需要更积极的抗银屑病治疗,包括生物制剂。
局限性
- PPP定义基于单次ICD-10编码,可能受诊断和记录实践差异影响。
- 三个研究人群的PPP患病率差异可能源于诊断和记录实践不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Palmoplantar pustulosis (PPP) is a chronic pustular skin condition on the palms and soles. The disease is often seen in combination with plaque psoriasis, and whether PPP is a variant of psoriasis has been debated. The disease prevalence of PPP and co-occurring psoriasis is not yet established and the patient group remains understudied. OBJECTIVES: To estimate the prevalence of PPP and co-occurring psoriasis in three population-based cohorts and to provide information on patient demographics and characteristics. METHODS: Administrative healthcare registries and insurance databases from the U.S.A., Denmark and Germany were used as data sources. Patients with PPP were defined by a single International Classification of Diseases 10th Revision code for PPP during a 1-year period. Information regarding co-occurring plaque psoriasis and other comorbidities was extracted. Furthermore, use of antipsoriatic medication was identified. RESULTS: In total 1435, 751 and 1832 patients with PPP were identified in the U.S., Danish and German populations, with estimated 1-year prevalences of 0·009%, 0·005% and 0·08%, respectively. Plaque psoriasis was present in 14·2-61·3% of patients with PPP. Patients with co-occurring psoriasis had an overall higher prevalence of psoriatic arthritis. Similarly, medication use was more prevalent in patients with PPP with co-occurring psoriasis, and especially pronounced was the use of biologic therapies. CONCLUSIONS: This large observational study on patients with PPP provides detailed information regarding patient demographics, comorbidities and medication use. The 1-year prevalence of PPP varied in the three studied populations, possibly due to differences in diagnostics and recording practices. Psoriasis frequently co-occurred in patients with PPP. What's already known about this topic? Palmoplantar pustulosis (PPP) is a skin disease of the palms of the hands and soles of the feet and is known to be related to psoriasis. Whether PPP is a distinct disease or a variant of psoriasis is not yet established. The condition is understudied in terms of disease prevalence, disease predictors, patient characteristics and comorbidity. What does this study add? In this study using data from three large population-based cohorts we found low prevalence rates (< 0·1%) of PPP. The prevalence of psoriasis was estimated at between 14·2% and 61·3% in patients with psoriasis. Patients with PPP with co-occurring psoriasis have a higher prevalence of psoriatic arthritis and use of antipsoriatic drugs.
引用
- Andersen YMF, Augustin M, Petersen J, et al. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis. Br J Dermatol. 2019. PMID: 30815849. doi:10.1111/bjd.17832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。